ES8700056A1 - Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer. - Google Patents

Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.

Info

Publication number
ES8700056A1
ES8700056A1 ES544306A ES544306A ES8700056A1 ES 8700056 A1 ES8700056 A1 ES 8700056A1 ES 544306 A ES544306 A ES 544306A ES 544306 A ES544306 A ES 544306A ES 8700056 A1 ES8700056 A1 ES 8700056A1
Authority
ES
Spain
Prior art keywords
same
related antigen
binding
glycosidic linkage
thermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544306A
Other languages
English (en)
Other versions
ES544306A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57177411A external-priority patent/JPS5967224A/ja
Priority claimed from JP58100528A external-priority patent/JPS59225119A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8700056A1 publication Critical patent/ES8700056A1/es
Publication of ES544306A0 publication Critical patent/ES544306A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ANTIGENOS RELACIONADOS CON EL ENLACE GLICOSIDICO DERIVADOS DE CELULAS DE CANCER, QUE SON UNA GLICOPROTEINA CON UNA ESTRUCTURA TERMINAL SACARIDICA DE GALACTOSA O N-ACETILGALACTOSAMINA. COMPRENDE LA HOMOGENEIZACION DE CELULAS CANCEROSAS CULTIVADAS, HUMANAS O ANIMALES, ESPONTANEAS, PROVOCADAS QUIMICA O VIRALMENTE, U ORIGINADAS EN TEJIDOS SOMETIDOS A INTERVENCIONES QUIRURGICAS, EN DISOLUCION SALINA FISIOLOGICA; SEPARACION DEL PRECIPITADO POR CENTRIFUGACION, SOLUBILIZACION DEL MISMO CON UN AGENTE TENSIOACTIVO Y RECOGIDA DEL SOBRENADANTE QUE RESULTA. REACCION DEL LIQUIDO SOBRENADANTE CON UN ANTICUERPO DE ANTIGENO QUE DERIVA DE CELULAS DE CANCER, POR MEDIOS FISIOCOQUIMICOS O BIOQUIMICOS CONVENCIONALES, PARA ENLAZAR UN GLICOPROTEINA Y, FINALMENTE, RECOGER DICHA GLICOPROTEINA. ESTOS ANTIGENOS TIENEN APLICACIONES PARA TRATAMIENTO Y PREVENCION DE CANCERES.
ES544306A 1982-10-08 1985-05-30 Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer. Expired ES8700056A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57177411A JPS5967224A (ja) 1982-10-08 1982-10-08 糖鎖関連抗原およびその製造法ならびにこれを有効成分とする抗癌剤
JP58100528A JPS59225119A (ja) 1983-06-06 1983-06-06 熱変性抗原の製造法

Publications (2)

Publication Number Publication Date
ES8700056A1 true ES8700056A1 (es) 1986-10-16
ES544306A0 ES544306A0 (es) 1986-10-16

Family

ID=26441535

Family Applications (2)

Application Number Title Priority Date Filing Date
ES526622A Expired ES8600692A1 (es) 1982-10-08 1983-10-07 Procedimiento de producir antigenos y sus intermedios
ES544306A Expired ES8700056A1 (es) 1982-10-08 1985-05-30 Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES526622A Expired ES8600692A1 (es) 1982-10-08 1983-10-07 Procedimiento de producir antigenos y sus intermedios

Country Status (8)

Country Link
EP (1) EP0106285A3 (es)
CA (1) CA1236016A (es)
DK (1) DK463283A (es)
ES (2) ES8600692A1 (es)
FI (1) FI80711C (es)
NO (1) NO833655L (es)
PH (1) PH23701A (es)
PT (1) PT77472B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
SE468231B (sv) * 1984-05-18 1992-11-23 Kabi Pharmacia Ab Foerfarande foer att paavisa smaacelligt lungcarcinomantigen och anvaendning av antikroppar mot fukosylsialosylgangliotetraos foer framstaellning av komposition foer behandling eller in vivo/ diagnos
JPH03263401A (ja) * 1990-03-13 1991-11-22 Nippon Koutai Kenkyusho:Kk 新規糖鎖
MD838G2 (ro) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
US5376531A (en) * 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
DK140992D0 (da) * 1992-11-24 1992-11-24 Ole Buchardt Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2112643B (en) * 1981-05-19 1984-08-30 Stephen Sugaar Strongly antigenic tumor specific substances and methods for detecting cancer using said substances
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer

Also Published As

Publication number Publication date
EP0106285A2 (en) 1984-04-25
FI833652A (fi) 1984-04-09
CA1236016A (en) 1988-05-03
PH23701A (en) 1989-09-27
DK463283A (da) 1984-04-09
ES526622A0 (es) 1985-11-01
FI80711C (fi) 1990-07-10
NO833655L (no) 1984-04-09
PT77472A (en) 1983-11-01
ES8600692A1 (es) 1985-11-01
DK463283D0 (da) 1983-10-07
FI80711B (fi) 1990-03-30
EP0106285A3 (en) 1987-09-02
FI833652A0 (fi) 1983-10-07
PT77472B (en) 1986-02-12
ES544306A0 (es) 1986-10-16

Similar Documents

Publication Publication Date Title
AU563356B2 (en) Conjugate of enzyme and antibody
BR1100843A (pt) Mak 195, linha celular hìbrida, processo de preparação de anticorpos monoclonais mak 195, aplicação do anticorpo monoclonal mak 195
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
GR3036951T3 (en) Cells with multiple altered epitopes on a surface antigen for use in transplantation
ES2176347T3 (es) Modulacion de la respuesta inmune.
WO1999058678A3 (en) Antibodies to dendritic cells and human dendritic cell populations and uses thereof
ES8700056A1 (es) Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.
EP0111005A4 (en) Fucose antigens, process for their preparation and antibodies for distinguishing them, a kit for diagnosing cancer containing the fucose antigens and a method for determining the sacchandic chains associated with cancer.
EP0270930A3 (en) Substantially pure enzyme-antibody conjugate preparations
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
HK1041273A1 (en) Compositions and method for generating monoclonal antibodies representative of a specific cell type
KR850007431A (ko) 글리코사이드 결합 관련 항원의 제조방법
CA2101534A1 (en) Monoclonal antibodies to putative hcv envelope region and methods for using same
IE880701L (en) Immunoglobulin conjugates
EP0109861A3 (en) Method for isolating cells
EP0306680A3 (en) Monoclonal antibodies to anti-thrombin binding substance, and their uses
Mark et al. B‐cell lymphoma marking only with anti‐epithelial. Membrane antigen
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
WO1986002651A3 (en) Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies
AU560262B2 (en) Antibodies derived from hybrid line from (myeloma + antibody producing cell)
KR840006439A (ko) 글리코사이드 결합된 항원의 제조방법
AU556941B2 (en) Glycosidic linkage related antigen
Baldwin et al. Monoclonal Antibodies Specifying Antigens Associated with Rat Tumors and Their Use in Drug Delivery Systems